Seung J. Kim^1,2,3, James I. MacDonald^1,2,4, Frederick A. Dick^1,2,4,*

¹London Regional Cancer Program, Lawson Health Research Institute, London, Ontario, Canada
²Children’s Health Research Institute, Lawson Health Research Institute, London, Ontario, Canada
³Department of Biochemistry, Western University, London, Ontario, Canada
⁴Department of Pathology and Laboratory Medicine, Western University, London, Ontario, Canada

^*For correspondence: Frederick A. Dick

The retinoblastoma tumor suppressor protein (RB) plays an important role in biological processes such as cell cycle control, DNA damage repair, epigenetic regulation, and genome stability. The canonical model of RB regulation is that cyclin-CDKs phosphorylate and render RB inactive in late G1/S, promoting entry into S phase. Recently, monophosphorylated RB species were described to have distinct cell-cycle-independent functions, suggesting that a phosphorylation code dictates diversity of RB function. However, a biologically relevant, functional role of RB phosphorylation at non-CDK sites has remained elusive. Here, we investigated S838/T841 dual phosphorylation, its upstream stimulus, and downstream functional output. We found that mimicking T-cell receptor activation in Jurkat leukemia cells induced sequential activation of downstream kinases including p38 MAPK and RB S838/T841 phosphorylation. This signaling pathway disrupts RB and condensin II interaction with chromatin. Using cells expressing a WT or S838A/T841A mutant RB fragment, we present evidence that deficiency for this phosphorylation event prevents condensin II release from chromatin.

Keywords : retinoblastoma protein, phosphorylation, p38 MAPK, T-cell receptor, chromatin structure